The growth of small cell lung cancer (SCLC) cells can be inhibited by apatinib via the decreased expression of CD31, Ki-67,VEGF, p-AKT, p-ERK1/2, p-PI3K, and pVEGFR-2 [14]. This evidence concerns the gene MAPK3 and small cell lung carcinoma.